A complex of cadherin 17 with desmocollin 1 and p120-catenin regulates colorectal cancer migration and invasion according to the cell phenotype

Rubén A. Bartolomé,Laura Pintado-Berninches,Ángela Martín-Regalado,Javier Robles,Tania Calvo-López,Marina Ortega-Zapero,Celia Llorente-Sáez,Issam Boukich,María Jesús Fernandez-Aceñero,J. Ignacio Casal
DOI: https://doi.org/10.1186/s13046-024-02956-6
IF: 12.658
2024-01-26
Journal of Experimental & Clinical Cancer Research
Abstract:Cadherin-17 (CDH17), a marker of differentiation in intestinal cells, binds and activates α2β1 integrin to promote cell adhesion and proliferation in colorectal cancer (CRC) metastasis. Furthermore, CDH17 associates with p120- and β-catenin in a manner yet to be fully elucidated. In this report, we explored the molecular mediators involved in this association, their contribution to CRC dissemination and potential therapeutic implications.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the interactions among cadherin 17 (CDH17), desmocollin 1 (DSC1) and p120 - catenin and their mechanism of action in the migration and invasion of colorectal cancer (CRC). Specifically, the researchers focused on how these proteins regulate the migration and invasion behaviors of CRC according to the cell phenotype (epithelial or mesenchymal), and explored the therapeutic significance of these molecular interactions for CRC subtypes. ### Research Background - **Proposing the Problem**: Metastasis is the main cause of death in patients with colorectal cancer, and changes in cadherins, catenins and related signaling pathways play a central role in cell - cell adhesion, cancer progression and metastasis. There is a conversion from DSC2 to DSC1/3 in CRC, similar to the classical cadherin conversion (such as the replacement of E - cadherin with N - cadherin), which is related to epithelial - mesenchymal transition (EMT). - **The Role of CDH17**: CDH17 is an atypical 7 - domain cadherin that binds to α2β1 integrin through its RGD motif and promotes CRC liver metastasis. In addition, CDH17 may also affect the progression and metastasis of CRC through other mechanisms, such as activating the Wnt/β - catenin signaling pathway. - **The Role of p120 - catenin**: The role of p120 - catenin in cancer progression is complex. Different isoforms (1, 3, 4) are expressed differently in different cell types, and their effects on cell invasion and proliferation are also different. ### Research Objectives - **Explore CDH17 - interacting Proteins**: Identify the interacting proteins of CDH17 in different CRC cell lines through proteomic analysis. - **Function Verification**: Verify the functions of DSC1 and p120 - catenin in CRC cells through cell experiments (such as cell adhesion, migration, invasion and proliferation experiments). - **In Vivo Experiments**: Verify the role of DSC1 in CRC metastasis and the inhibitory effect of synthetic peptides on the DSC1/CDH17 complex through animal experiments. ### Main Findings - **The Interaction between CDH17 and DSC1**: The study found that DSC1 interacts with CDH17 through its extracellular domain, and this interaction exhibits different functions in different cell phenotypes. - **The Function of DSC1**: Knockdown of DSC1 increases invasion in CRC cells with an epithelial phenotype and decreases invasion in CRC cells with a mesenchymal phenotype. This process is mediated by the interaction with p120 - catenin. - **The Regulation of p120 - catenin**: Knockdown of DSC1 leads to an increase in the expression of p120 - catenin isoform 1 in epithelial cells, while in mesenchymal cells, it shows a change in cell localization. - **Therapeutic Potential**: The synthetic peptide NLV can effectively inhibit the invasion and liver homing of CRC cells, providing the possibility for developing new therapeutic strategies. ### Conclusion This study reveals the multifaceted roles of CDH17, DSC1 and p120 - catenin in CRC metastasis, providing new insights for therapeutic interventions targeting desmosomal cadherins. In particular, the expression of DSC1 in different CRC subtypes is related to prognosis, providing a potential target for personalized treatment.